Tesamorelin 20mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview Tesamorelin is a research peptide studied for its relevance to growth-hormone–related pathways metabolic regulation models and controlled biochemical analysis involving peptide–receptor interactions. This lyophilized 20 mg preparation supports laboratory evaluation of identity purity and mechanistic behaviour.   Peptide Overview Between 2010 and 2025 Tesamorelin attracted broad scientific attention due to its role in growth-hormone regulation modelling and its measurable activity in controlled in-vitro systems. Its defined analytical profile allows consistent biochemical research under reproducible laboratory conditions.   Historical Background and Scientific Context Research into GH secretagogue analogues expanded significantly from 2012 onward as laboratories explored peptides that modulate metabolic pathways and GH-related mechanisms. Tesamorelin became a reference compound for modelling metabolic turnover, GH signalling and energy-regulation pathways.   Mechanistic Focus in Research

• GH-related signalling and metabolic-pathway modelling
• In-vitro analysis of peptide–receptor interaction
• Comparative profiling of GH secretagogue peptides
• Structure–function evaluation in controlled biochemical systems
• Energy-regulation and metabolic-response pathway studies

  Analytical Verification (COA) Independent Liquilabs analysis confirms validation for Batch GF092025036. Key results include:

• Assay Content: 20.8 mg
• Identification – Retention Time: 0.992
• Identification – Spectrum: 988
• Purity: 99.0%
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count, yeast or mold
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were confirmed using validated chromatographic, spectroscopic and microbiological procedures ensuring full traceability and transparent documentation.   Research Applications

• Metabolic-pathway and GH-signalling modelling
• Receptor-binding biochemical studies
• Comparative GH secretagogue evaluation
• Energy-regulation and metabolic-response experiments
• Controlled in-vitro structure–function analysis

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Purity 99.0% with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin level below 0.001 EU per mg
• Batch GF092025036 – Published October 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.